Armata Pharmaceuticals, Inc.
COMPANY
10-Q
FORM
2026-05-13
FILING DATE
2026-03-31
Q1 PERIOD END
537
FACTS
SIC 2836
CIK 0000921114
Taxonomy US GAAP 2025  
SIC 2836
CIK 0000921114
Taxonomy US GAAP 2025  
Standard Concepts
264
Extended Concepts
56
18%
Extended Concepts
Errors
0
What are errors?
What are errors?
Indicate problems with an XBRL formatted filing that are sufficient grounds for SEC rejection of the XBRL portion of the filing.
Data Quality Errors
0
What are data quality errors?
What are data quality errors?
Indicate areas that may not meet the standards set by the Data Quality Committee (DQC), and may reveal areas where the XBRL can be improved.
Possible Issues
4
WARNING
Concept IncomeStatementLocationAxis in us-gaap/2025 used in 4 facts was deprecated as of 2026 and should not be used.
WARNING
Concept ResearchAndDevelopmentExpenseMember in us-gaap/2025 used in 2 facts was deprecated as of 2026 and should not be used.
WARNING
Concept GeneralAndAdministrativeExpenseMember in us-gaap/2025 used in 2 facts was deprecated as of 2026 and should not be used.
WARNING
2 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:CommitmentsAndContingencies
What are possible issues?
What are possible issues?
Indicate areas of interest as to the quality of an XBRL formatted filing, and in some cases reveal opportunities for improvement of the XBRL filing.
SEC: Filing | Interactive Data